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Use of 132 microglobulin to diagnose tubulo-interstitial renal lesions in
children. Fractional excretion (FE) of 132 microglobulin (f32M) was
studied in children with glomerular (N 114), tubular (N 50) or
other (N = 18) renal diseases. FE-f32M (normal C 0.36%) was signifi-
cantly (P cc 0.001) lower in glomerular diseases (mean 0.104%) than in
tubular lesions (mean 4.27%). Unexpectedly, several patients with
glomerular disease were found to have increased values for FE-f32M. To
determine whether this was due to a tubular component in a primary
glomerular disease process, FE-132M was measured in 30 children with
various glomerulopathies who underwent renal biopsy. Thirteen of
these patients had tubulo-interstitial lesions in addition to their glomer-
ular disease. FE-/32M in these patients averaged 3.76% (range 0.14 to
44.6%); only two results were normal. Mean FE-thM in the 17 patients
without biopsy evidence of tubulo-interstitial disease was 0.063%
(range 0.02 to 0.34%); all values were in the normal range. The types of
glomerular diseases in the two groups of patients were similar. Patients
with a glomerular lesion complicated by tubulo-interstitial lesions had a
poorer prognosis than did those with a pure glomerular disease. The
high incidence of tubulo-interstitial lesions in patients with glomerular
diseases was unexpected. Our data demonstrates that FE-thM repre-
sents a reliable non-invasive method to diagnose such involvement.
Measurements of f32M also provide a convenient method to follow the
course and response to treatment of renal tubular injury.
j32-mieroglobulin (Ø2M), a protein with a molecular wt of
11,800 daltons, is present on the cell surface of most nucleated
cells [I] as the small subunit of HLA class I antigens [2].
Measurable concentrations of the protein are present in most
biologic fluids [3]. Levels in the serum reflect both the produc-
tion and excretion rates of the protein. Under most conditions,
production rates and serum concentrations of f32M are remark-
ably stable, although increased values may be seen with malig-
nancies [4, 51, in infections [6], and with certain immunologic
disorders [7]. Since the kidney represents the major excretory
pathway for the protein, alterations in serum Ø2M concentra-
tions most often result from changes in the level of renal
function. Indeed, it has been suggested that changes in the
serum level of thM may be a better indicator of alteration in
glomerular filtration rate (GFR) than equivalent levels of creat-
mine [8].
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The removel of 2M from the serum is primarly by glomerular
filtration although some peritubular uptake of the protein may
also occur [91. The glomerular sieving coefficient for /32M
exceeds 0.8 [10] so that large quantities of the protein are
filtered each day. More than 99.9% of the filtered protein is
reabsorbed and catabolized by the proximal convoluted tubule.
Consequently, normal urine contains low concentnstions of
f32M—typically less than 360 fkg/liter [11], except in the neo-
nate. The urinary levels of f32M peak by the fifth day of life and
show a gradual decline until normal adult values are reached by
three months of age [12]. No tubular maximum (Tm) for human
f32M reabsorption has been found [9] so that the filtered load of
2M has little, if any, effect on the urinary loss of this protein.
Thus, most studies suggest that the urinary excretion of 132M is
determined primarily by proximal tubular function. Tubular
damage secondary to ischemia [131 and to a variety of toxins
[14] and drugs [15—19] results in increased urinary levels of2M.
The present study was undertaken to assess the clinical
usefulness of /32M determinations in diagnosing tubular involve-
ment in a wide variety of renal diseases in children. We
investigated whether this noninvasive test could be helpful in
separating tubular from glomerular diseases and in following the
course and treatment of patients with tubular diseases.
Methods
One hundred and eighty-two children whose ages ranged
from one to nineteen years and who had a variety of renal
diseases (Table 1) were studied. The diagnosis was established
by renal biopsy in those patients where it could not be estab-
lished from clinical and laboratory data. Patients receiving
known nephrotoxic drugs such as aminoglycosides [17],
methieillin [18], methotrexate [19], those exposed to heavy
metals [14], those receiving parental hyperalimentation [20] and
those with active urinary tract infections [21, 22] or sepsis [231
were excluded from the study since the renal handling of p2M
has been shown to be modified in these conditions. Patients
receiving immunosuppressive agents were included in the
study, These agents are not known to alter the tubular handling
of f32M, although they can cause a reduction in serum levels by
decreasing production [24]. Several of the patients were studied
serially so that there were 241 observations on the 182 patients.
Concentrations of $2M in serum and urine were measured in
172 of these children at the time that GFR was measured by
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inulin clearance using standard clearance methodology [251. In
these studies, after the volume of voided urine had been
measured, an aliquot of the urine was collected for /32M
determination. The pH of all these samples was > 5.5, a level at
which $2M degradation does not occur [261, and in 215 of the
226 samples, pH ranged between 6 and 7. Nevertheless, every
sample was further alkalinized immediately with 0.1 N sodium
hydroxide to a pH of> 6.5 to ensure no decomposition of f32M
which occurs in acid urines [27]. The remaining 10 children all
of whom had acute tubular necrosis, did not have inulin
clearance measurements. In these children, FE-J32M was calcu-
lated from creatinine and f32M levels in urine and plasma
obtained simultaneously.
Urine and serum were analyzed for p2M by a commercially
available radioimmunoassay (Phadebus-50, Pharmacia, Up-
psala, Sweden). Samples not analyzed on the day of collection
Table 1. A summary of the patients studied and their results
Number Cj,,im
FE-/32M Urinary p2M
Number of Number of
Disease studied of mi/mm/I .73 normal normal
number of patients observations m2 (%) observations (mg/I) observations
Glomerular diseases
Acute nephritis 12 84.3* 0.069** 11 0.058 11
N = 12 (0.032—0.894) (0.021—1.89)
SLE nephritis 30 83.6 0.053 28 0.051 27
N = 20 (0.003—3.8) (0.003—6.7)
Membranoproliferative GN 9 46.2 0.724 5 0.338 5
N = 6 (0.06—16.1) (0.01—17.2)
Membranous GN 7 54.1 4.57 1 2.24 0
N = 2 15.4 (0.32—16.7) (1.4—17.2)
HSP nephritis 22 96.2 0.091 19 0.06 21
N = 18 (0.03—3.24) (0.01—2.6)
Hemolytic uremic syndrome 10 87.2 0.06 10 0.06 9N = 9 12.7 (0.01—0.30) (0.01—0.18)
IgAnephropathy 6 106.4 0.102 6 0.32 6N = 3 (0.03-0.2) (0.02—0.08)
Hem, and/or Prot.t 27 105.4 0.74 27 0.064 27N 27 10.8 (0.02—0.26) (0.01—0.12)
Familial nephritis 9 93.4 0.077 9 0.048 9
N = 7 (0.02—0.16) (0.02—0.06)
MCNStt 7 96.6 0.079 7 0.128 6
N = 7 (0.01—0.205) (0.05—1.3)
Focal sclerosing GN 4 80.1 1.51 1 3.24 1
N = 3 (0.11—8.8) (0.1—17)
All glomerulopathies 143 88.3 0.104 124 0.274 122N 114 (0.01—16.7) (0.01—17.2)
Tubular diseases
Obstructionlpyelonephritis 23 51.3 1.045 11 0.492 11N = 22 (0.04—50.3) (0.006—22.4)
Dysplasia 10 32.8 5.5 1 2.82 3N = 8 (0.36—105) (0.11—67.2)
Cystinosis 4 64.6 52.0 0 3.24 1N = 4 (13.8—68.7) (0.05—25.9)
Fanconi syndrome 12 87.1 10.5 0 8.91 0N 2 (1.8-99.6) (10.4—27.9)
Interstitial nephritis 7 47.0 2.95 1 1.66 1
N = 4 (0.08—36) (0.05—16.8)
Acute tubular necrosis 15 — 11.8 1 6.76 0
N = 10 (0.27—80.7) (0.4—30.8)
All tubular disorders 71 54.4 4.27 14 2.24 16
N = 50 (0.03—105) (0.01—67.2)
Other diseases
Glycogen storage dis. 3 97.2 0.398 2 0.812 2N 3 (0.04—30) (0.02—14.6)
Polycystic kidney 5 112.6 0.068 5 0.039 5N = 5 (0.04—0.10) (0.01—0.09)
Renal tubular acidosis 11 101 0.155 8 0.151 8
N = 8 (0.03—1.9) (0.04—1.3)
Renal artery stenosis 8 83.5 0.05 8 0.074 7N=2 (0.01—0.18) (0.02—0.44)
All other disorders 27 96.9 0.11 23 0.01 22
N = 18 (0.01—30) (0.01—14.6)
* Mean so; ** Mean with observed range; Hematuria and/or proteinuria; Minimal change nephrotic syndrome.
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were frozen at —70°C until analyzed. Preliminary studies
showed that freezing did not affect j32M concentration, although
repeated freezing and thawing did decrease these levels. Repro-
ducibility in our laboratory for repeated /32M measurements on
serum and urine samples was 4.8%. Fractional excretion
(FE) of 2M was calculated from the standard formula [281
using the inulin concentrations measured in the same urine and
serum samples. In the age range of patients studied, the normal
serum values for f32M range from 1.1 to 2.4 (mean 1.6) mg/liter,
the normal range for FE-JM from 0.01 to 0.36% [241 and the
normal urine concentration of /32M is 360 .rg/liter or less [11, 28,
29]. In 44 of the children, urine and plasma samples were also
analyzed for creatinine by a modified Jaffe method [301 to
permit comparison of creatinine and inulin when calculating
FE-f32M.
Of the children studied, 30 who were thought to have a
glomerulonephritis, underwent renal biopsy to determine the
nature of their renal disease. The need for percutaneous renal
biopsy was determined by clinical criteria. In no case was the
biopsy performed to obtain data for the study. The biopsy
specimens were processed by standard pathological techniques
for evaluation by light, immunofluorescent and electron micros-
copy. The pathologist was asked to evaluate these specimens
for evidence of tubulointerstitial disease without knowledge of
the 7M results which had been measured on the day before the
renal biopsy was performed.
Data was analyzed by standard statistical methodology [31].
Distribution of values for serum and urine /.32M were skewed.
These values were subjected to logarithmic transformation
before analysis. Statistical significance was considered estab-
lished with a P value of < 0.05. The study was approved by the
Human Studies Committee of Washington University before
any data was obtained.
Results
Serum ,62M concentration
Serum f32M correlated well with FGR (Fig. I). Patients were
divided into those who had diseases which were primarily
glomerular, those with tubular disorders and those with other
renal diseases. Visual inspection of the data suggested there
were no differences between results from these groups. This
was confirmed when data from each group was analyzed
separately. There were no significant differences between the
lines of regression calculated by the method of least squares for
the three groups of patients.
Fractional excretion of l32M
The values for FE-2M in each of the disease categories are
summarized in Table 1. One hundred and forty-three observa-
tions were made on 114 patients with glomerular diseases. The
mean value for FE-p2M in this group was 0.104% (Table 1)
which is well within the normal range. One hundred and
twenty-four of the individual results were normal. Abnormal
(elevated) values were most often seen in patients with either
membranoproliferative or membranous glomerulonephritis. In-
creased values were observed occasionally in most other
glomerulopathies. Results from patients with nephrotic syn-
drome varied depending on the underlying disease process.
Normal values occurred in all patients who had minimal change
20 40 60 80 100 120 140
Cirh, mi/min/173 m2
Fig. I. The relationship between serum concentration of 132M and GFR
in patients with different ftrms of renal disease. The regression line and
correlation coefficient were calculated from all the values, irrespective
of the underlying type of renal diseases. Symbols are: (.) glomerular
diseases; (0) tubular diseases; (A) other diseases. r = 0.78, P < 0.001.
nephrotic syndrome; in contrast, those with focal sclerosis
tended to have increased values for FE-/32M.
Of the 71 observations made on 50 patients with diseases
associated with tubular damage, only 14 were in the normal
range. The mean value for FE-/32M in this group of patients was
4.27% or almost 12 times the upper limit of normal. This value
was signifcaritly (P <0.001) increased from that in patients with
glomerular diseases. Markedly elevated levels were found in
many of the patients with tubular lesions. For example, the
fractional excretion of f32M averaged 10.5% in subjects with the
Fanconi Syndrome, 11.8% in those with acute tubular necrosis,
and more than 50% in those with cystinosis. Variable results
were seen in patients with obstructive uropathy and chronic
pyelonephritis. Some of these patients had very high values,
others were in the normal range; none of these patients had
clinical or laboratory evidence for active infection at the time of
study to account for such a variation in results.
Most of the patients with other renal disorders had normal
FE-7M values. For example, each of the patients with poly-
cystic kidney disease had a normal result, although it should be
emphasized that these studies were performed early in the
course of the lesion when all the values for GFR were in the
normal range. Whether comparable results occur in patients
with longer standing lesions, was not evaluated,
Thirty-six of the 182 patients were studied twice. Values for
FE-p2M agreed with one another in 34 of these children. One of
the two patients with discordant values had membranoprolifera-
live glomerulonephritis; the initial value was normal, the repeal
study six months later was elevated. FE-/32M was increased and
GFR decreased in one patient during the acute nephritic phase
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of Henoch—Schonlein purpura; both results were normal in the
second study four months later. Two patients were studied
three times; each value for FE-f32M was normal in both of these
patients; FE-2M was consistently elevated in the two patients
with Fanconi syndrome who were studied a total of 12 times.
Three patients had four studies each. In two of these patients all
values for FE-2M were in agreement; in the third, who had
membranous glomerulonephritis, the initial value was normal
but each of the three subsequent values was increased.
FE-/32M was related to GFR. Patients with reduced values for
GFR tended to have the higher values for FE-132M. Since, as a
group, patients with glomerular diseases had better preserved
levels of GFR than did those with tubular lesions (88.3 26.7
and 54.4 30.0 mlIminIl.73 m2 respectively; P < 0.001), the
data was re-analyzed to determine whether differences in GFR
accounted for the different values for FE-/32M in patients with
glomerular and those with tubular diseases. In patients with
tubular disorders, there was a significant inverse correlation
between GFR and FE-/32M (r = 0.83; P < 0.001). Patients with
glornerular diseases did not show an equivalent correlation (r =
0.04; NS). In Figure 2, values for FE-f32M are compared in
patients with tubular and those with glomerular diseases at
different levels of GFR. At any given GFR, patients with
tubular disorders had higher values for FE-/32M than did those
with glomerular disorders. The higher values for FE-f32M at
lower levels of GFR in the patients with tubular disease are
apparent in this figure.
Creatinine as a glomerular marker
All of the preceeding values, except those in patients with
acute tubular necrosis where clearances were not obtained,
were calculated using inulin as the glomerular marker. Forty-
four patients with varying diagnoses (25 patients with glomer-
ular disease and 19 with tubular lesions) and a wide range of
values for inulin clearance (21 to 119 ml/min/1.73 m2) had
fractional excretions of f32M calculated from inulin and from
creatinine concentrations determined on the same samples.
There was excellent agreement between the results from the
two methods with a correlation coefficient of 0.97 (P < 0.001).
Thus, the data obtained in the present study can be applied
equally well in situations in which creatinine rather than inulin
is used to measure renal function.
Urine f32M concentrations
Results of the study were analyzed further using urine p2M
concentrations rather than FE-J32M. The correlation between
FE- and urinary concentration of f32M was highly significant (r
= 0.90; P < 0.001: Fig. 3). The correlation coefficient was
higher for patients with tubular lesions (r = 0.94) than for those
with glomerular diseases (r = 0.67). In each disease category
the number of normal results using either FE-f32M or urinary
f32M agreed well (Table 1). Presuming that FE-/32M predicted
tubular function accurately, urinary f32M levels correlated with
FE-/32M in predicting normal tubular function in 159 of 161
instances (98.8% accuracy). Conversely, urinary 2M was
0.001 NS P < 0.001 P < 0.01 P < 0.01
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Fig. 2. The fraclional excretion of f32M in patients with glomerular and those with tubular renal diseases at different levels of GFR. Patients with
glomerular diseases that had biopsy proven tubulo-interstitial disease were excluded from this analysis. Mean values and standard deviations are
shown. The number of patients in a group is depicted within each bar. Symbols are: tubular disease; glomerular disease.
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Fig. 3 The relationship between fractional excretion and urinary con-
centration of B2M in the 241 studies. The results are platted according
to the patient's type of disease but the regression line and correlation
coefficient are calculated from all the observations. Symbols are same
as Figure 1. r = 0.89; P < 0.001.
accurate in 72 of 80 instances (90.0% accuracy) in predicting
tubular damage based on the FE-/32M.
Repeated determinations of urinary [32M levels in individual
patients usually agreed, although consistency was slightly less
good than that for FE-/32M. Discordant results were obtained in
three of the 36 patients studied twice, and in one sample each
from a patient studied three times and one studied four times.
Renal biopsy ond the FE-f32M
As indicated above, some patients with apparently pure
glomerular disease had elevated values for FE-[32M (Table 1).
One explanation for this unexpected observation is that these
patients could have a tubular component to their disease
process. To determine whether this might he the case, FE-[32M
was measured prospectively in 30 children with glomerular
disease who were to undergo a renal biopsy. The renal biopsies
were reviewed by one of the authors (JMK) for evidence of
tubulo-interstitial disease without knowledge of the 132M data.
Of these 30 patients, 17 had no evidence of tubulo-interstitial
disease; their FE-$2M averaged 0.063% with an observed range
of 0.02 to 0.34% (Table 2). Each value felt into the normal
range.
The remaining 13 patients had an interstitial nephritis. In six,
the lesion consisted of focal areas of mild or moderate degrees
of lymphocytic infiltration often accompanied by mild
insterstitial edema, More marked lesions, including focal areas
of fibrosis, were present in another four patients, one of whom
had plasma cells as well as lymphocytes in the infiltrate.
Tubular atrophy was seen in the remaining three patients. In
one this was associated with extensive areas of chronic
lymphocytic and plasma cell infiltration in the interstitium. In
another, eosinophils as well as mononuclear cells were present
in the infiltrate. The third had diffuse interstitial fibrosis with
IgO, IgA, 1gM and C3 demonstrated in the interstitium by
immunofluoreseent microscopy. This was one of two patients in
whom immunoglobulins or complement were identified in the
interstitium.
Three patients had had previous renal biopsies. In two,
biopsies performed two and four years earlier respectively,
showed no evidence of interstitial disease. In both, the biopsies
performed at the time of the /32M study demonstrated severe
chronic interstitial inflammation. The third patient showed an
inflammatory interstitial infiltrate consisting primarily of neu-
trophils at the time he presented with immune complex glomer-
ulonephritis. Five years later, when he appeared to have
recovered clinically, scattered areas of lymphocytie infiltration
were the only abnormalities in the interstitium on a repeat
biopsy. Twelve years after disease onset, the patient had rapid
deterioration in renal function, and a third biopsy revealed
atrophic tubules accompanied by interstitial fibrosis and im-
mune complex deposits as already described.
The presence or absence of tubulo-interstitial disease was not
associated with a particular glomerular or systemic disease.
Thus, there were no tubulo-interstitial lesions in seven patients
with systemic lupus erythematosus, three with MCNS, two
with Henoch—Schoenlein Purpura, two with IgA nephropathy
and one patient each with proliferative glomerulonephritis,
membranous glomerulonephriti s, and mesangial glomerulone-
phritis. The group with tubulo-interstitial involvement com-
prised three patients with systemic lupus erythematosus, three
with membranous glomerulonephritis, two with Henoch—
Schoenlein Purpura, two with membranoproliferative glomeru-
lonephritis and one each with proliferative glomerulonephritis,
rapidly progressive glomerulonephritis, and focal sclerosing
glomerulonephritis.
FE-/32M in the 13 patients with tubulo-interstitial disease
averaged 3.76% (observed range 0.14 to 44.6%). Only two of the
13 results were in the normal range. The highest values for
FE-f32M tended to occur in patients with the most severe
pathologic changes but increased values occurred also in pa-
tients in whom interstitial but no tubular lesions were seen on
the biopsy.
Measurements of urinary /32M concentrations forecast the
absence of tubulo-interstitial disease in 16 of 17 cases in which
this lesion was not present, and predicted the presence of such
disease in 10 of 13 cases. Thus the precision of urinary p2M
levels was slightly less than that of FE-[32M.
The presence of tubulo-interstitial lesions was associated
with a poor outcome. Eight of the 13 patients with this lesion
progressed to end—stage renal disease (ESRD). Only one of the
17 patients without tubulo-interstitial lesions developed ESRD
(P < 0.005). The length of follow-up for the two groups of
patients was comparable when either time from study (Table 2)
or time from onset of disease (6.9 2.9 yrs vs. 7.1 3.2 yrs,
respectively: NS) to the present was analyzed. The nine pa-
tients who developed ESRD have been followed for 57.6 15.1
months since study compared to 48.2 23.8 months (NS) for
those who did not develop ESRD.
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Table 2. Comparison of FE-2M results from patients with glomerular disease and biopsy proven presence or absence of tubulo-interstitial
disease
Fractional Patients
excretion
of /32M
%
No of values. progressing
to ESRD
N
Length* of
follow—up
monthsNormal Elevated
No tubulo-interstjtial lesions 0.0635* 17 0 1 52.7N = 17 (0.02—0.34)
2 11 8 48.7N = 13 (0.14—44.6)
P < O.0Ol P < 0.001" P < 0.005" NS
Symbols are: From time of study to present. Mean SD; ** Mean withobserved range; Determined by Student's t-test; Determined by Chi—
square.
Discussion
Measurements of 132M have been used for a number of clinical
purposes. Urinary concentrations of the protein can identify
renal tubular injury from heavy metals [14] and acute tubular
necrosis [13]. Even mild tubular dysfunction, for example that
in neonates with meconium stained amniotic fluid, can be
identified by measurement of 132M [32]. Other reported uses for
the measurement of the protein include differentiation of upper
from lower urinary tract infections [211 and assessment of renal
tubular maturation in neonates [33]. Serum levels of /32M have
been used to predict renal transplant rejection [34, 351 and to
monitor diabetic nephropathy [361. Indeed, it has been sug-
gested that changes in serum levels of p2M may be a better
indicator of changes in GFR, especially in children, than serum
creatinine since the rate of production of /32M is not body mass
dependent as is creatinine. In one study of 250 patients with
various renal diseases, GFR estimated from serum levels of
/32M were almost as reliable as values calculated from the
clearance of 99m TC-DTPA [37]. Other studies have not con-
firmed such a relationship [38]. We found a statistically signif-
icant correlation between levels of serum /32M and GFR (Fig.
1). Moreover, values from patients with glomerular, tubular and
other renal diseases overlapped completely. Unfortunately,
serum f3,M values varied considerably at any level of GFR so
that it was not possible to predict GFR with accuracy from
serum /32M values.
Urinary measurements of M, in contrast to serum levels,
permitted the separation of patients with tubular disorders from
those with glomerular diseases. Elevated values for FE-2M
were observed in children with tubular diseases (Table 1) and
the mean value for this group of patients was more than 40 times
higher than the equivalent value in patients with glomerulopath-
ies. At any given level of GFR, patients with tubular disorders
had higher values for FE-/32M than did those with glomerular
diseases (Fig. 2) although there was overlap in results from the
two groups of patients. It was at the lowest levels of GFR where
the separation was most complete. In agreement with previous
studies [39] patients with glomerulonephritis and a markedly
reduced GFR had normal values for FE-2M; those with
tubular diseases had elevated FE-f32M results. The excellent
diagnostic value of measurements of FE-2M in identifying the
existence of a tubular lesion is illustrated by the findings in the
30 patients who were thought to have a glomerular disease and
who underwent renal biopsy. Thirteen of these patients had
tubulo-interstitial lesions of whom 11 had high values for
FE-1M. None of the patients without tubulo-interstitial in-
volvement had elevated FE-f32M levels. The high incidence of
these tubulo-interstitial lesions in the biopsied patients probably
resulted from the indications used to establish the need for the
biopsy. The clinical and laboratory findings in these patients
were atypical and necessitated the establishment of an exact
histologic diagnosis. Tubular disease was not suspected prior to
biopsy, except in one patient who had had a previous biopsy.
These observations indicate that measurements of FE-/32M
help to differentiate tubular from glomerular disease and will
identify tubular involvement in a primary glomerular disease.
The elevated values for FE-/32M in tubular disorders are most
likely due to tubular damage, which reduces the ability of the
proximal tubule to reabsorb the filtered load of this protein. We
were unable to correlate the urinary excretion of 132M in our
patients with the calculated filtered load of the protein, even if
the sieving coefficient for f32M in renal disease was assumed to
be 1.0. Since serum J32M values from patients with glomerular,
tubular and other renal diseases overlapped completely (Fig. I),
there is no evidence that the sieving coefficient for this protein
varied in the different disease categories, Thus, there is no
evidence to support the concept that the elevated levels of
urinary /32M were due to a marked increase in filtered load of
2M which overwhelmed tubular reabsorption of this protein.
Other studies support this conclusion. For example, the maxi-
mum tubular reabsorptive capacity for /32M could not be
exceeded either when serum f32M levels were markedly in-
creased in patients with normal renal function [38] or by
infusions of the protein [91.
Since 2M measurements appear to be such a good indicator
of tubular injury, they could have additional clinical uses to
those already discussed. We found that sequential measure-
ments provided useful information about changes in the level of
tubular function. For example, the initial FE-f32M values in
patients with acute tubular necrosis averaged 33.0 13.1%;
they fell progressively to 9.0 4.2% by 10 to 20 days into the
disease course and eventually returned to normal in those
patients who were followed long—term. Another example of the
usefulness of repeated values was provided by a three year old
boy who had inflammatory bowel disease and chronic diarrhea.
He developed a nephrotic syndrome. A renal biopsy demon-
strated membranous glomerulonephritis and an immunologi-
cally mediated tubulo-interstitial disease which was associated
with the Fanconi syndrome. His initial value for FE-/32M was
[32 Microglobulin in renal tubular disease 97
96.6%. This value fell rapidly and progressively to below 6%
within one month of instituting treatment with steroids. Re-
lapses of the tubular disease were subsequently predicted by
increasing values for FE-J3M, which occurred before any
changes in GFR, amino—aciduria, or metabolic acidosis were
documented.
Measurements of FE-f32M could have additional diagnostic
value. For example, all the children with nephrotic syndrome
secondary to MCNS had normal FE-M results; those with
other causes such as focal sclerosis, membranous glomerulone-
phritis or membranoproliferative glomerulonephritis frequently
had elevated values. Children with polycystic kidney disease
had normal values for FE-7M; those with renal dysplasia
tended to have elevated levels, Perhaps most importantly,
FE-f32M may help to determine prognosis for patients. We
found that patients who had a glomerular disease complicated
by tubular involvement had elevated values for FE-f32M and a
poorer prognosis than did those in whom only the glomeruli
were diseased (Table 2). The correlation between tubulo-inter-
stitial lesions and poor prognosis has been noted previously
[401, our observations indicate that measurements of FE-/32M
help to identify those patients at risk.
The current observations suggest that measurements of uri-
nary /32M concentration represent an excellent screening test
for detecting tubulo-interstitial disease. If these values are
elevated, FE-J32M should be measured for a more precise
indicator of the presence of renal tubular disease. It must be
remembered, however, that all of the current studies were
performed under standardized conditions of mild diuresis which
was induced to increase the accuracy of simultaneous measure-
ments of inulin clearance. In addition, urine samples were
alkalinized immediately upon collection to minimize the decom-
position of 132M which occurs in an acid urine [27]. Whether
random samples obtained under a variety of non-standard
conditions would be equally reliable as a diagnostic tool was not
evaluated in this study. In summary, the present study demon-
strates that measurement of 2M, especially FE-p2M, provides
a reliable method to identify tubular injury in renal disease
states and may provide a useful guide to help determine
prognosis in patients with these lesions,
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